ASPARGO

90455390 | Trademark

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Filed Jan. 8, 2021
Serial No. 90455390
Examining Attorney KATHERINE DUBRAY
Class Pharmaceuticals compounds for the treatment of erectile dysfunction; sildenafil; oral spray formulation of sildenafil; house mark for pharmaceuticals for the treatment of erectile dysfunction; medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for the treatment of erectile dysfunction; 005; 006; 018; 044; 046; 051; 052; 026; 039; 044
ASPARGO
Case Type Trademark
Status A fifth request for extension of time to file a Statement of Use has been granted.
Opposition 90455390
Sun Pharmaceutical Industries Limited v. Aspargo Laboratories, Inc.
  • Aspargo Laboratories, Inc.;
  • Sun Pharmaceutical Industries Limited;
Last Updated: 1 day, 23 hours ago
Filing Date # Docket Text
12/2/2024
12/2/2024
12/2/2024SOU EXTENSION 5 GRANTED
12/2/2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/26/2024
11/26/2024SOU TEAS EXTENSION RECEIVED
11/26/2024SOU EXTENSION 5 FILED
8/6/2024
6/13/2024
6/13/2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
5/31/2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
5/30/2024
5/30/2024
5/30/2024SOU TEAS EXTENSION RECEIVED
5/30/2024SOU EXTENSION 4 FILED
5/30/2024SOU EXTENSION 4 GRANTED
11/30/2023
11/30/2023
11/30/2023ASSIGNED TO EXAMINER
11/30/2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/29/2023
11/29/2023SOU TEAS EXTENSION RECEIVED
11/29/2023SOU EXTENSION 3 FILED
11/29/2023SOU EXTENSION 3 GRANTED
8/10/2023
8/10/2023
8/10/2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
8/9/2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
8/9/2023SOU EXTENSION 2 GRANTED
7/4/2023
7/4/2023
7/4/2023NOTICE OF REVIVAL - E-MAILED
7/3/2023
7/3/2023
7/3/2023ABANDONMENT - NO USE STATEMENT FILED
7/3/2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
7/3/2023TEAS PETITION TO REVIVE RECEIVED
7/3/2023PETITION TO REVIVE-GRANTED
7/3/2023SOU EXTENSION RECEIVED WITH TEAS PETITION
5/31/2023SOU EXTENSION 2 FILED
11/30/2022
11/30/2022
11/30/2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/28/2022
11/28/2022SOU TEAS EXTENSION RECEIVED
11/28/2022SOU EXTENSION 1 FILED
11/28/2022SOU EXTENSION 1 GRANTED
5/31/2022
5/31/2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
4/14/2022EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
3/25/2022
3/24/2022POST PUBLICATION AMENDMENT - ENTERED
3/23/2022ASSIGNED TO PETITION STAFF
3/16/2022
3/16/2022TEAS POST PUBLICATION AMENDMENT RECEIVED
11/4/2021EXTENSION OF TIME TO OPPOSE RECEIVED
11/4/2021TTAB Proceeding Filed: Sun Pharmaceutical Industries Limited v. Aspargo Laboratories, Inc., 90455390
10/5/2021
10/5/2021PUBLISHED FOR OPPOSITION
10/5/2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
9/15/2021
9/15/2021
9/15/2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
8/28/2021
8/28/2021
8/27/2021
8/27/2021EXAMINERS AMENDMENT -WRITTEN
8/27/2021EXAMINERS AMENDMENT E-MAILED
8/27/2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
8/27/2021EXAMINER'S AMENDMENT ENTERED
8/27/2021APPROVED FOR PUB - PRINCIPAL REGISTER
7/28/2021
7/28/2021
7/28/2021NON-FINAL ACTION WRITTEN
7/28/2021NON-FINAL ACTION E-MAILED
7/28/2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
7/19/2021ASSIGNED TO EXAMINER
4/8/2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
1/12/2021NEW APPLICATION ENTERED
1/8/2021
1/8/2021